Barbara Sosnowski, PhD
Barbara is a former Vice President at Pfizer responsible for identifying innovative research opportunities spanning multiple therapeutic areas that are both strategically aligned as well as complimentary to scientific efforts within World-Wide Research and Development. She built and lead a global team of 18 senior and executive scientists to identify First in Class or Only in class assets in innovative technology platforms. Barbara lead multiple cross functional teams within Pfizer to conduct due diligence and present findings at both the WRD Leadership and Executive Leadership levels. She is known for thinking creatively to solve challenges and for digging in-deep to get to the root of issues. She is a Pfizer Achievement Award recipient for recognition of visionary insights and innovation and holds board memberships on Mass Bio, UCLA Technology Development Group, Molecular Stethoscopes and Ab Initio.